Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy (POPB-TOX)
Sponsor: University Hospital, Brest
This PHASE3 trial investigates Obstetrical Brachial Plexus Palsy and is currently actively recruiting participants. University Hospital, Brest leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Mar 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Jan 2024 [monthly]
Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Nov 2020 [monthly]
Recruiting PHASE3
-
Nov 2018 — Mar 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Brest
For direct contact, visit the study record on ClinicalTrials.gov .